Penumbra PEN - 옵션 체인 | ADVFN

다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

Penumbra Inc (PEN)

277.69

-8.69

(-3.03%)

마감 07 3월 6:00AM

277.69

0.00

( 0.00% )

시간외 단일가: 9:14PM

PEN 실시간 옵션 플로우

콜

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
190.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
195.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
200.00	76.10	80.00	0.00	78.05	0.00	0.00 %	0	0	-
210.00	66.20	70.10	0.00	68.15	0.00	0.00 %	0	0	-
220.00	56.50	60.20	0.00	58.35	0.00	0.00 %	0	0	-
230.00	46.60	50.50	0.00	48.55	0.00	0.00 %	0	0	-
240.00	37.00	40.60	0.00	38.80	0.00	0.00 %	0	0	-
250.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
260.00	19.00	22.60	44.20	20.80	0.00	0.00 %	0	2	-
270.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
280.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
290.00	2.95	5.20	7.90	4.075	0.00	0.00 %	0	2,524	-
300.00	1.10	3.30	2.20	2.20	-1.40	-38.89 %	2	729	07/03/2025
310.00	0.55	2.50	2.60	1.525	0.00	0.00 %	0	37	-
320.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
330.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
340.00	1.85	1.70	1.85	1.775	0.00	0.00 %	0	400	-
350.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
360.00	0.00	1.75	0.00	0.00	0.00	0.00 %	0	0	-
370.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

개인 투자자를 위한 전문가급 도구.

풋

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
190.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
195.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
200.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
210.00	0.00	2.25	0.00	0.00	0.00	0.00 %	0	0	-
220.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
230.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
240.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
250.00	1.05	1.90	1.00	1.475	0.00	0.00 %	0	6	-
260.00	1.50	4.40	2.00	2.95	0.00	0.00 %	0	11	-
270.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
280.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
290.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
300.00	22.40	25.40	16.70	23.90	0.00	0.00 %	0	15	-
310.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
320.00	40.70	44.50	0.00	42.60	0.00	0.00 %	0	0	-
330.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
340.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
350.00	70.00	74.80	0.00	72.40	0.00	0.00 %	0	0	-
360.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
370.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

가장 활성
% 상승자
% 패자

기호	가격	볼륨
SUNESUNation Energy Inc	US$ 0.4409 (148.96%)	123.11M
HFBLHome Federal Bancorp Inc of Louisiana	US$ 19.85 (53.88%)	5
BBGIBeasley Broadcast Group Inc	US$ 9.99 (53.46%)	37
VTVTvTv Therapeutics Inc	US$ 25.00 (49.88%)	4
LARKLandmark Bancorp Inc	US$ 33.99 (46.83%)	3
LUNRIntuitive Machines Inc	US$ 6.92 (-38.54%)	2.33M
SYRESpyre Therapeutics Inc	US$ 13.01 (-36.54%)	69
PROVProvident Financial Holdings Inc	US$ 11.20 (-24.78%)	18
USCBUSCB Financial Holdings Inc	US$ 14.20 (-20.89%)	12
BFINBankFinancial Corporation	US$ 10.21 (-20.48%)	25
SUNESUNation Energy Inc	US$ 0.4409 (148.96%)	123.11M
FAMIFarmmi Inc	US$ 0.2935 (28.39%)	39.51M
PSTVPlus Therapeutics Inc	US$ 2.04 (41.67%)	22M
CTMXCytomX Therapeutics Inc	US$ 0.8124 (31.61%)	18.01M
ICONIcon Energy Corporation	US$ 0.17 (17.24%)	10.33M

@LaughinPaulRyan

@LaughinPaulRyan 4 년 전

... ALL NEWS IS GOOD? ... $PEN

CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

@LaughinPaulRyan

@LaughinPaulRyan 4 년 전

QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company

@LaughinPaulRyan

@LaughinPaulRyan 4 년 전

Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients

davidsson10

davidsson10 4 년 전

https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

@LaughinPaulRyan

@LaughinPaulRyan 4 년 전

... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020

TREND1

TREND1 10 년 전

IPO INFO

http://www.marketwatch.com/tools/ipo-calendar

TREND1

TREND1 10 년 전

IPO NOW HAS SYMBOL
Penumbra PEN

TREND1

TREND1 10 년 전

IPO should be out soon.
no symbol yet.

Societe Generale Effekten

Region Nouvelle Aquitain...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관